CorMedix
CRMD
54 hedge funds and large institutions have $20M invested in CorMedix in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 5 closing their positions.
64% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 11
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
24% more capital invested
Capital invested by funds: $16.2M → $20M (+$3.83M)
4% more funds holding
Funds holding: 52 → 54 (+2)
0.22% less ownership
Funds ownership: 4.51% → 4.29% (-0.22%)
98% less call options, than puts
Call options by funds: $21K | Put options by funds: $1.24M
Top Buyers
| 1 |
Group One Trading
Chicago,
Illinois
|
+$237K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$126K |
| 3 |
Goldman Sachs
New York
|
+$88.6K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$79.2K |
| 5 |
GLRA
Gerald L. Ray & Associates
Dallas,
Texas
|
+$69.9K |
Top Sellers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$488K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$296K |
| 3 |
ST
Spot Trading
Chicago,
Illinois
|
-$226K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$180K |
| 5 |
Millennium Management
New York
|
-$122K |
CRMD Hedge Fund Activity: Q1 2016 in Review
54 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q1 2016, worth a combined $20M — up 24% from $16.2M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CRMD positions and 5 closed out — a net gain of 2 holders — while 18 added to existing stakes and 11 trimmed.
The largest buyer was Group One Trading, adding an estimated $237K. The largest seller was AQR Capital Management, cutting an estimated $488K.
- 54 institutional investors held CorMedix (CRMD) as of Q1 2016, up from 52 in Q4 2015.
- Funds reported $20M of CorMedix stock for Q1 2016, up 24% quarter-over-quarter.
- 7 funds opened new CorMedix positions in Q1 2016 and 5 closed out, a net change of +2 holders.
- The largest CorMedix buyer in Q1 2016 was Group One Trading, an estimated $237K added.
- The largest CorMedix seller in Q1 2016 was AQR Capital Management, an estimated $488K sold.
Based on aggregated 13F filings for Q1 2016.